acebutolol and Restless Leg Syndrome

acebutolol has been researched along with Restless Leg Syndrome in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (63.64)24.3611
2020's4 (36.36)2.80

Authors

AuthorsStudies
Allen, RP; Chen, ML; DelRosso, LM; Ferri, R; Kapoor, V; Mogavero, MP; Picchietti, DL1
Hu, F; Ji, C; Li, S; Liu, B; Long, J; Ming, M; Ren, H; Wang, F; Xu, Z; Yang, B; Yang, X; Zhu, Z1
Amrein, K; Drexler, C; Herster, C; Holter, M; Macher, S; Matzhold, EM; Moritz, M; Pieber, TR; Schlenke, P; Stojakovic, T1
Allen, RP; Choi, SJ; Joo, EY; Park, HR1
Allen, RP; Bae, H; Cho, YW; Earley, CJ; Kim, KT1
Mezzacasa, A; Oertel, W; Roubert, B; Trenkwalder, C; Virgin, G; Winkelmann, J1
Allen, RP; Cho, YW; Earley, CJ2
Bassetti, C; Baumann, C; Gyr, T; Hübner, A; Krafft, A; Manconi, M; Schneider, J; Werth, E1
Adler, CH; Allen, RP; Bregman, DB; Butcher, A; Du, W; Earley, CJ1
Hornyak, M; Kassubek, J; Kiemen, A; Scholz, H1

Reviews

1 review(s) available for acebutolol and Restless Leg Syndrome

ArticleYear
Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
    Sleep medicine, 2019, Volume: 61

    Topics: Ferric Compounds; Ferric Oxide, Saccharated; Humans; Injections, Intravenous; Iron-Dextran Complex; Maltose; Observational Studies as Topic; Randomized Controlled Trials as Topic; Restless Legs Syndrome

2019

Trials

5 trial(s) available for acebutolol and Restless Leg Syndrome

ArticleYear
The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
    Nutrients, 2020, May-05, Volume: 12, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Blood Donors; Dietary Supplements; Fatigue Syndrome, Chronic; Female; Ferric Compounds; Humans; Infusions, Intravenous; Iron, Dietary; Male; Maltose; Middle Aged; Quality of Life; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome; Young Adult

2020
Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
    Sleep medicine, 2021, Volume: 84

    Topics: Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Humans; Maltose; Restless Legs Syndrome; Treatment Outcome

2021
Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:10

    Topics: Aged; Aged, 80 and over; Female; Ferric Compounds; Ferritins; Hematinics; Humans; Iron Metabolism Disorders; Male; Maltose; Middle Aged; Prospective Studies; Restless Legs Syndrome; Single-Blind Method; Time Factors; Treatment Outcome

2017
Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
    Sleep medicine, 2018, Volume: 42

    Topics: Administration, Intravenous; Double-Blind Method; Female; Ferric Compounds; Humans; Male; Maltose; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome

2018
Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Sleep medicine, 2011, Volume: 12, Issue:9

    Topics: Adult; Aged; Brain; Female; Ferric Compounds; Ferritins; Follow-Up Studies; Humans; Iron; Male; Maltose; Middle Aged; Pilot Projects; Placebos; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome

2011

Other Studies

5 other study(ies) available for acebutolol and Restless Leg Syndrome

ArticleYear
Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
    Sleep medicine, 2021, Volume: 87

    Topics: Child; Ferric Compounds; Humans; Maltose; Nocturnal Myoclonus Syndrome; Restless Legs Syndrome; Retrospective Studies; Treatment Outcome

2021
Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
    Sleep medicine, 2020, Volume: 75

    Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Maltose; Restless Legs Syndrome; Retrospective Studies; Treatment Outcome

2020
Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
    Sleep medicine, 2015, Volume: 16, Issue:11

    Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferritins; Humans; Maltose; Pilot Projects; Pregnancy; Pregnancy Complications; Prospective Studies; Restless Legs Syndrome; Switzerland; Time Factors; Treatment Outcome

2015
Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
    Sleep medicine, 2016, Volume: 25

    Topics: Administration, Intravenous; Adult; Asian People; Double-Blind Method; Female; Ferric Compounds; Humans; Iron; Male; Maltose; Middle Aged; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Trace Elements; Treatment Outcome

2016
Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Sleep medicine, 2012, Volume: 13, Issue:6

    Topics: Adult; Aged; Comorbidity; Female; Ferric Compounds; Ferritins; Humans; Injections, Intravenous; Iron; Iron Deficiencies; Male; Maltose; Middle Aged; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome

2012